Ophthalmic compositions containing loratadine
    10.
    发明授权
    Ophthalmic compositions containing loratadine 有权
    含有氯雷他定的眼用组合物

    公开(公告)号:US06635654B1

    公开(公告)日:2003-10-21

    申请号:US10340355

    申请日:2003-01-09

    IPC分类号: A61K3144

    CPC分类号: A61K9/0048 A61K31/4545

    摘要: The present invention is directed to an ophthalmic formulation which comprises a therapeutically effective amount of ethyl 4-(8-chloro-5,6-dihydro-11-benzo[5,6]cyclohepta[1,2-b]pyridin-11-ylidene)-1-piperidinecarboxylate, known as loratadine, a fatty acid ester, and a surfactant, which has been found to be useful in treating ocular allergies, especially allergic conjunctivitis, and related conditions.

    摘要翻译: 本发明涉及一种眼用制剂,其包含治疗有效量的4-(8-氯-5,6-二氢-11-苯并[5,6]环庚并[1,2-b]吡啶-11- 已经被发现可用于治疗眼部过敏症,特别是过敏性结膜炎和相关病症的已知的氯雷他定,脂肪酸酯和表面活性剂的亚胺基-1-哌啶羧酸酯。